Mascoma Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7K Hold
98
﹤0.01% 262
2025
Q4
$20.2K Hold
98
﹤0.01% 260
2025
Q3
$17.6K Hold
98
﹤0.01% 271
2025
Q2
$15.8K Hold
98
﹤0.01% 282
2025
Q1
$16.7K Hold
98
﹤0.01% 280
2024
Q4
$16.3K Hold
98
﹤0.01% 296
2024
Q3
$16.8K Hold
98
﹤0.01% 279
2024
Q2
$15.1K Hold
98
﹤0.01% 289
2024
Q1
$15.1K Hold
98
﹤0.01% 278
2023
Q4
$15.5K Sell
98
-2
-2% -$287 ﹤0.01% 288
2023
Q3
$14.6K Hold
100
﹤0.01% 296
2023
Q2
$15.1K Hold
100
﹤0.01% 290
2023
Q1
$15.4K Hold
100
﹤0.01% 367
2022
Q4
$15.4K Hold
100
﹤0.01% 365
2022
Q3
$13K Hold
100
﹤0.01% 372
2022
Q2
$14K Hold
100
﹤0.01% 382
2022
Q1
$15K Hold
100
﹤0.01% 398
2021
Q4
$16K Hold
100
0.01% 355
2021
Q3
$17K Buy
+100
New +$17.1K 0.01% 306
2021
Q2
Sell
-100
Closed -$16K 221
2021
Q1
$16K Buy
+100
New +$17.1K 0.01% 317
2019
Q3
Sell
-100
Closed -$14K 168
2019
Q2
$14K Hold
100
0.01% 246
2019
Q1
$15K Hold
100
0.01% 243
2018
Q4
$12K Hold
100
0.01% 244
2018
Q3
$16K Hold
100
0.01% 250
2018
Q2
$14K Hold
100
0.01% 252
2018
Q1
$13K Hold
100
0.01% 253
2017
Q4
$14K Hold
100
0.01% 242
2017
Q3
$12K Hold
100
0.01% 269
2017
Q2
$11K Hold
100
0.01% 278
2017
Q1
$11K Buy
+100
New +$10K 0.01% 253

Other funds holding FBT

Mascoma Wealth Management's FBT Position: Q1 2026 in Review

Mascoma Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 98 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #262.

Mascoma Wealth Management first reported a position in FBT in Q1 2017 and has held it in 30 quarters since. The position peaked at $20.2K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Mascoma Wealth Management held 98 shares of First Trust NYSE Arca Biotechnology Index Fund worth $19.7K as of Q1 2026.
  • Mascoma Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q1 2026, its #262 holding.
  • Mascoma Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and has held it in 30 quarters since.
  • Mascoma Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $20.2K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Mascoma Wealth Management's 13F filing for Q1 2026, filed 30 Apr 2026.